01 7Halaven
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 359
2019 Revenue in Millions : 385
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 331
2020 Revenue in Millions : 344
Growth (%) : 4
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 316
2021 Revenue in Millions : 331
Growth (%) : -4
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 260
2022 Revenue in Millions : 316
Growth (%) : -8
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 380
2016 Revenue in Millions : 371
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 365
2017 Revenue in Millions : 356
Growth (%) : 2%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 378
2018 Revenue in Millions : 377
Growth (%) : 0
LOOKING FOR A SUPPLIER?
